Form D · Biotechnology

Canton Strategic Holdings, Inc.

Red Bank, NJ · CIK 0001861657

Offering snapshot reported Apr 15, 2026 · SEC filing

Reported sold
$1.74M
Offering amount: $1.74M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 23, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 15, 2026Initial$1,740,000No comparison13SEC filing
Apr 15, 2026Initial$1,225,003No comparison6SEC filing
Jul 7, 2025Initial$2,500,000No comparison30SEC filing
Dec 17, 2024Initial$2,020,000No comparison7SEC filing
Jun 28, 2024Initial$2,084,160No comparison5SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$122K
Finders' fees
$0
Form D file number
021-580534
Received placement agent warrants to purchase 52,128 shares of common stock with a strike price of $1.66.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
President Street Global LLC000318377

Source: Form D, filed Apr 15, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kelly Anderson Director
Sireesh Appajosyula Director
Jacob Asbury Executive
Lynne A/ Bui Director
Thomas Hess Executive
Clay Kahler Director
James Gordon Liddy Director
Vincent Lo Priore Director
Leonard Mazur Director
Randy Milby Director, Executive
Sanam Parikh Director
Angela Radkowski Executive
Jill Sommers Director
Gary Stetz Director
Mark Toomey Executive
Mark Wendland Director, Executive
William Wiley Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
34 Shrewsbury Ave.
Red Bank, NJ, 07701